We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Streck Launches Rapid, Modular qPCR Instrument with Market-Leading Speed

By LabMedica International staff writers
Posted on 11 Nov 2020
Streck (La Vista, NE, USA) has launched the Zulu RT, a rapid, modular qPCR instrument capable of performing four independent experiments simultaneously. It can perform a 40-cycle, 6-channel 3-step real-time PCR in less than 20 minutes, making it the fastest qPCR instrument in the world.

The Zulu RT uses unique, proprietary Streck thermal technology combined with powerful optics for market-leading speed. The Zulu RT does not sacrifice test volume for speed; it provides less than 20-minute qPCR for volumes from 10 up to 50 µL. Ramp speeds of 15°C/second heating, 12°C/second cooling and precise thermal control allows the Zulu RT to perform rapid, 6-color detection faster than any other instrument in the world for large volumes.

Image: Zulu RT (Photo courtesy of Streck)
Image: Zulu RT (Photo courtesy of Streck)

The modularity of the system allows greater flexibility in testing, allowing multiple users at one time; in essence, acting as four individual thermal cyclers in one. The Zulu RT can speed assay development and ease sample processing backlogs and scheduling for busy laboratories. Designed for speed and flexibility, the Zulu RT is ideally suited for esoteric testing, rapid needs testing and research use.



New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Thyroid Test
Anti-Thyroid EIA Test

Latest Industry News

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
11 Nov 2020  |   Industry

FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy
11 Nov 2020  |   Industry

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition
11 Nov 2020  |   Industry



ADLM